S. Koerner

发表

Molecular Magnetic Resonance Imaging of Lung Fibrogenesis with an Oxyamine-Based Probe.

A. Tager, Howard H. Chen, P. Caravan, 2017, Angewandte Chemie.

Modulation of lymphocyte-mediated tissue repair by rational design of heterocyclic aryl hydrocarbon receptor agonists

A. Emili, M. Bhasin, E. Chaikof, 2020, Science Advances.

Design and synthesis of emodin derivatives as novel inhibitors of ATP-citrate lyase.

V. Sukhatme, E. Shuto, Lijun Sun, 2017, European journal of medicinal chemistry.

Discovery and optimization of a series of 3-(3-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amines: orally bioavailable, selective, and potent ATP-independent Akt inhibitors.

K. Nguyen, M. Ashwell, R. Nicewonger, 2012, Journal of medicinal chemistry.

Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor.

A. Matsuda, B. Schwartz, Steffi Koerner, 2016, Journal of medicinal chemistry.

Novel synthetic chalcones induce apoptosis in the A549 non-small cell lung cancer cells harboring a KRAS mutation.

Lijun Sun, B. Wegiel, A. Hedblom, 2016, Bioorganic & medicinal chemistry letters.

EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus.

Peter Caravan, P. Caravan, T. McMurry, 2008, Journal of the American Chemical Society.

Collagen-targeted MRI contrast agent for molecular imaging of fibrosis.

Biplab Das, Patrick A Helm, Peter Caravan, 2007, Angewandte Chemie.

Topical Application Of A Mast Cell Stabilizer Improves Impaired Diabetic Wound Healing.

Ting-Yu Shih, M. Bhasin, D. Mooney, 2020, The Journal of investigative dermatology.

Structure-activity relationship study and discovery of indazole 3-carboxamides as calcium-release activated calcium channel blockers.

A. Veves, Lijun Sun, M. Nagai, 2017, Bioorganic & medicinal chemistry letters.

A lysine walk to high relaxivity collagen-targeted MRI contrast agents.

Biplab Das, Peter Caravan, Wei-Chuan Sun, 2009, Chemical communications.

Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor.

A. Matsuda, B. Schwartz, R. Savage, 2016, Journal of medicinal chemistry.

Design and synthesis of emodin derivatives as novel inhibitors of ATP-citrate lyase.

V. Sukhatme, Lijun Sun, J. Hanai, 2017, European journal of medicinal chemistry.